The three year grant, worth over £140,000, forms part of over £4.2 million invested in research by Campaign in the last year.
Dr Martin will study a group of molecules called redox proteins which are thought to help breast cancer cells survive. By examining 2,000 breast cancer samples he hopes to discover whether these proteins play a role in the development of breast cancer and whether they are resistant to breast cancer treatments such as chemotherapy and radiotherapy.
Dr Martin said “The results of this project may help clinicians to select the most appropriate treatments for patients and the development of breast cancer treatments in the future.”
Pamela Goldberg, Chief Executive, Breast Cancer Campaign said “Thanks to real progress in breast cancer research we have seen significant improvements in diagnosis, treatment and survival. Breast cancer research is saving lives and our mission is to beat breast cancer by funding world class research projects such as Dr Martin’s to keep up the momentum of bringing us closer to a cure.”
Emma Thorne | Source: alphagalileo
Further information: www.nottingham.ac.uk
More articles from Health and Medicine:
Immune system activated in schizophrenia
20.11.2009 | Karolinska Institutet
New research helps explain why bird flu has not caused a pandemic
20.11.2009 | Imperial College London
Scientists Unravel Evolution of Highly Toxic Box Jellyfish
20.11.2009 | Life Sciences
When good companies do bad things: Examining illegal corporate behavior
20.11.2009 | Business and Finance
UCR plant scientist's research spawns new discoveries showing how crops survive drought
20.11.2009 | Agricultural and Forestry Science
Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients
20.11.2009 | Event News
'Golden Age' for clinical psychology in Northern Ireland
20.11.2009 | Event News
New Perspectives in Marine Anti-Fouling Research
11.11.2009 | Event News